 |
|
Systematic Review and Meta-Analysis of Damage Associated Molecular Patterns HMGB1 and S100B in Schizophrenia
Michael Mackey, Laurena Holleran, Gary Donohoe, Declan P. McKernan
Psychiatry Investig. 2022;19(12):981-990. Published online 2022 Dec 22 DOI: https://doi.org/10.30773/pi.2022.0173
|
|
Systematic Review and Meta-Analysis of Damage Associated Molecular Patterns HMGB1 and S100B in Schizophrenia
Michael Mackey, Laurena Holleran, Gary Donohoe, Declan P. McKernan
Psychiatry Investigation.2024; 21(1): 109. CrossRef Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?
Song Chen, Yunlong Tan, Li Tian
Molecular Psychiatry.2024;[Epub] CrossRef Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs
Miriam Ouadih-Moran, Antonio Muñoz-Hoyos, Luis D’Marco, Antonio Molina-Carballo, Isabel Seiquer, Ana Checa-Ros
Nutrients.2023; 15(3): 712. CrossRef Biochemical and Anthropometric Parameters for the Early Recognition of the Intrauterine Growth Restriction and Preterm Neonates at Risk of Impaired Neurodevelopment
Maria Cristina Aisa, Benito Cappuccini, Alessandro Favilli, Alessandro Datti, Vincenza Nardicchi, Giuliana Coata, Sandro Gerli
International Journal of Molecular Sciences.2023; 24(14): 11549. CrossRef Mini review: Current status and perspective of S100B protein as a biomarker in daily clinical practice for diagnosis and prognosticating of clinical outcome in patients with neurological diseases with focus on acute brain injury
Tammam Abboud, Veit Rohde, Dorothee Mielke
BMC Neuroscience.2023;[Epub] CrossRef Peripheral S100B Protein Levels in Five Major Psychiatric Disorders: A Systematic Review
Tomasz Kozlowski, Weronika Bargiel, Maksymilian Grabarczyk, Maria Skibinska
Brain Sciences.2023; 13(9): 1334. CrossRef
|